Harrow, Inc. (NASDAQ:HROW) Shares Purchased by Teacher Retirement System of Texas

Teacher Retirement System of Texas grew its stake in shares of Harrow, Inc. (NASDAQ:HROW) by 18.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,951 shares of the company’s stock after buying an additional 1,408 shares during the period. Teacher Retirement System of Texas’ holdings in Harrow were worth $300,000 at the end of the most recent reporting period.

A number of other institutional investors also recently made changes to their positions in the stock. JPMorgan Chase & Co. increased its position in Harrow by 443.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 238,367 shares of the company’s stock worth $10,717,000 after purchasing an additional 194,480 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Harrow by 195.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 251,629 shares of the company’s stock valued at $11,313,000 after purchasing an additional 166,602 shares in the last quarter. BNP Paribas Financial Markets boosted its stake in shares of Harrow by 3,015.5% during the 3rd quarter. BNP Paribas Financial Markets now owns 79,974 shares of the company’s stock worth $3,596,000 after purchasing an additional 77,407 shares during the last quarter. Barclays PLC grew its holdings in shares of Harrow by 301.9% during the third quarter. Barclays PLC now owns 52,593 shares of the company’s stock worth $2,365,000 after buying an additional 39,506 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of Harrow in the third quarter valued at approximately $1,469,000. 72.76% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently issued reports on HROW shares. B. Riley decreased their target price on shares of Harrow from $69.00 to $65.00 and set a “buy” rating on the stock in a research report on Tuesday. HC Wainwright reissued a “buy” rating and set a $57.00 price target on shares of Harrow in a research note on Monday.

Harrow Trading Down 6.1 %

Shares of HROW stock opened at $24.98 on Wednesday. The firm’s 50-day simple moving average is $28.53 and its 200-day simple moving average is $37.72. The company has a debt-to-equity ratio of 3.23, a current ratio of 1.55 and a quick ratio of 1.44. Harrow, Inc. has a 1-year low of $9.86 and a 1-year high of $59.23. The firm has a market cap of $889.66 million, a P/E ratio of -26.57 and a beta of 0.69.

Harrow (NASDAQ:HROW) last issued its quarterly earnings results on Thursday, March 27th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.11 by $0.14. Harrow had a negative net margin of 19.75% and a negative return on equity of 45.57%. The firm had revenue of $66.83 million during the quarter, compared to analyst estimates of $66.01 million. As a group, equities analysts forecast that Harrow, Inc. will post -0.53 EPS for the current year.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.